Novartis and Merck Negotiating $5B Asset Trade

Jan 09, 2014


Novartis AG is in talks with Merck & Co. to trade its animal-health and human vaccines businesses for the New Jersey drugmaker’s over-the-counter health-products unit, according to sources familiar with the matter.

Merck’s over-the-counter business, including Coppertone sunblock and Claritin allergy medicine, would complement Novartis’s preexisting consumer line-up.

In exchange, Merck would aquire Novartis' human vaccines unit and add Novartis' line of treatments for pets, farm animals and cultivated fish to its already successful animal-health portfolio. Merck says its animal-health business is currently the second-biggest in the industry, with $3.40 billion in sales in 2012.

Read the Bloomberg press release

Join the discussion

We welcome your thoughtful comments. Please comply with our Community rules.
All comments will display your user name.

Want to participate in the discussion?

Register for free

Log in for complete access.


No one has commented on this page yet.

RSS feed for comments on this page | RSS feed for all comments